Literature DB >> 31696388

Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.

Yu Zhang1, Yifeng Zhu1, Kai Zhang1, Yajie Liu1, Jingjing Cui2, Juan Tao3, Yingzi Wang4, Shaowu Wang5.   

Abstract

PURPOSE: The purpose of this study is to develop a radiomics model for predicting the Ki-67 proliferation index in patients with invasive ductal breast cancer through magnetic resonance imaging (MRI) preoperatively.
MATERIALS AND METHODS: A total of 128 patients who were clinicopathologically diagnosed with invasive ductal breast cancer were recruited. This cohort included 32 negative Ki67 expression (Ki67 proliferation index < 14%) and 96 cases with positive Ki67 expression (Ki67 proliferation index ≥ 14%). All patients had undergone diffusion-weighted imaging (DWI) MRI before surgery on a 3.0T MRI scanner. Radiomics features were extracted from apparent diffusion coefficient (ADC) maps which were obtained by DWI-MRI from patients with invasive ductal breast cancer. 80% of the patients were divided into training set to build radiomics model, and the rest into test set to evaluate its performance. The least absolute shrinkage and selection operator (LASSO) was used to select radiomics features, and then, the logistic regression (LR) model was established using fivefold cross-validation to predict the Ki-67 index. The performance was evaluated by receiver-operating characteristic (ROC) analysis, accuracy, sensitivity and specificity.
RESULTS: Quantitative imaging features (n = 1029) were extracted from ADC maps, and 11 features were selected to construct the LR model. Good identification ability was exhibited by the ADC-based radiomics model, with areas under the ROC (AUC) values of 0.75 ± 0.08, accuracy of 0.71 in training set and 0.72, 0.70 in test set.
CONCLUSIONS: The ADC-based radiomics model is a feasible predictor for the Ki-67 index in patients with invasive ductal breast cancer. Therefore, we proposed that three-dimensional imaging features from ADC maps could be used as candidate biomarker for preoperative prediction the Ki-67 index noninvasively.

Entities:  

Keywords:  Invasive ductal breast cancer; Ki-67; MRI; Radiomics

Mesh:

Substances:

Year:  2019        PMID: 31696388     DOI: 10.1007/s11547-019-01100-1

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  33 in total

1.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

Review 2.  Radiomics: extracting more information from medical images using advanced feature analysis.

Authors:  Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts
Journal:  Eur J Cancer       Date:  2012-01-16       Impact factor: 9.162

3.  Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer.

Authors:  Yan-Qi Huang; Chang-Hong Liang; Lan He; Jie Tian; Cui-Shan Liang; Xin Chen; Ze-Lan Ma; Zai-Yi Liu
Journal:  J Clin Oncol       Date:  2016-05-02       Impact factor: 44.544

4.  Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.

Authors:  A Goldhirsch; W C Wood; A S Coates; R D Gelber; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2011-06-27       Impact factor: 32.976

5.  Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma.

Authors:  Fu-Sheng Ouyang; Bao-Liang Guo; Bin Zhang; Yu-Hao Dong; Lu Zhang; Xiao-Kai Mo; Wen-Hui Huang; Shui-Xing Zhang; Qiu-Gen Hu
Journal:  Oncotarget       Date:  2017-08-24

6.  Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.

Authors:  E de Azambuja; F Cardoso; G de Castro; M Colozza; M S Mano; V Durbecq; C Sotiriou; D Larsimont; M J Piccart-Gebhart; M Paesmans
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640

7.  Integration of DCE-MRI and DW-MRI Quantitative Parameters for Breast Lesion Classification.

Authors:  Roberta Fusco; Mario Sansone; Salvatore Filice; Vincenza Granata; Orlando Catalano; Daniela Maria Amato; Maurizio Di Bonito; Massimiliano D'Aiuto; Immacolata Capasso; Massimo Rinaldo; Antonella Petrillo
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

8.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Authors:  Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

9.  The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer.

Authors:  Cuishan Liang; Yanqi Huang; Lan He; Xin Chen; Zelan Ma; Di Dong; Jie Tian; Changhong Liang; Zaiyi Liu
Journal:  Oncotarget       Date:  2016-05-24

10.  Radiomics and radiogenomics for precision radiotherapy.

Authors:  Jia Wu; Khin Khin Tha; Lei Xing; Ruijiang Li
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

View more
  26 in total

1.  Delta radiomics: a systematic review.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Luca Boldrini; Giovanna Vacca; Emma D'Ippolito; Salvatore Annunziata; Alessandra Farchione; Maria Paola Belfiore; Isacco Desideri; Salvatore Cappabianca
Journal:  Radiol Med       Date:  2021-12-04       Impact factor: 3.469

Review 2.  Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence.

Authors:  Hiroko Satake; Satoko Ishigaki; Rintaro Ito; Shinji Naganawa
Journal:  Radiol Med       Date:  2021-10-26       Impact factor: 3.469

Review 3.  AI-enhanced breast imaging: Where are we and where are we heading?

Authors:  Almir Bitencourt; Isaac Daimiel Naranjo; Roberto Lo Gullo; Carolina Rossi Saccarelli; Katja Pinker
Journal:  Eur J Radiol       Date:  2021-07-30       Impact factor: 4.531

4.  Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Giovanna Vacca; Giuliana Giacobbe; Antonio Angrisani; Alfredo Clemente; Ginevra Danti; Pierpaolo Correale; Salvatore Francesco Carbone; Luigi Pirtoli; Lorenzo Bianchi; Angelo Vanzulli; Cesare Guida; Roberto Grassi; Salvatore Cappabianca
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

Review 5.  Radiomics in medical imaging: pitfalls and challenges in clinical management.

Authors:  Roberta Fusco; Vincenza Granata; Giulia Grazzini; Silvia Pradella; Alessandra Borgheresi; Alessandra Bruno; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Andrea Giovagnoni; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2022-03-28       Impact factor: 2.701

6.  Radiomics and Artificial Intelligence Analysis with Textural Metrics Extracted by Contrast-Enhanced Mammography in the Breast Lesions Classification.

Authors:  Roberta Fusco; Adele Piccirillo; Mario Sansone; Vincenza Granata; Maria Rosaria Rubulotta; Teresa Petrosino; Maria Luisa Barretta; Paolo Vallone; Raimondo Di Giacomo; Emanuela Esposito; Maurizio Di Bonito; Antonella Petrillo
Journal:  Diagnostics (Basel)       Date:  2021-04-30

7.  An update on radiomics techniques in primary liver cancers.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venazio Setola; Igino Simonetti; Diletta Cozzi; Giulia Grazzini; Francesca Grassi; Andrea Belli; Vittorio Miele; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2022-03-04       Impact factor: 2.965

Review 8.  Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma.

Authors:  Vincenza Granata; Roberta Grassi; Roberta Fusco; Andrea Belli; Carmen Cutolo; Silvia Pradella; Giulia Grazzini; Michelearcangelo La Porta; Maria Chiara Brunese; Federica De Muzio; Alessandro Ottaiano; Antonio Avallone; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2021-07-19       Impact factor: 2.965

9.  An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver.

Authors:  Zongren Ding; Kongying Lin; Jun Fu; Qizhen Huang; Guoxu Fang; Yanyan Tang; Wuyi You; Zhaowang Lin; Zhan Lin; Xingxi Pan; Yongyi Zeng
Journal:  World J Surg Oncol       Date:  2021-06-21       Impact factor: 2.754

10.  Radiomics in hepatic metastasis by colorectal cancer.

Authors:  Vincenza Granata; Roberta Fusco; Maria Luisa Barretta; Carmine Picone; Antonio Avallone; Andrea Belli; Renato Patrone; Marilina Ferrante; Diletta Cozzi; Roberta Grassi; Roberto Grassi; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2021-06-02       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.